Cargando…
Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report
BACKGROUND: Since introducing the SARS-CoV-2 vaccination, different adverse effects and complications have been linked to the vaccine. Variable neurological complications have been reported after receiving the COVID-19 vaccine, such as acute encephalopathy. CASE PRESENTATION: In this report, we desc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420261/ https://www.ncbi.nlm.nih.gov/pubmed/34512961 http://dx.doi.org/10.1016/j.amsu.2021.102803 |
_version_ | 1783748901735497728 |
---|---|
author | Al-Mashdali, Abdulrahman F. Ata, Yaser M. Sadik, Nagham |
author_facet | Al-Mashdali, Abdulrahman F. Ata, Yaser M. Sadik, Nagham |
author_sort | Al-Mashdali, Abdulrahman F. |
collection | PubMed |
description | BACKGROUND: Since introducing the SARS-CoV-2 vaccination, different adverse effects and complications have been linked to the vaccine. Variable neurological complications have been reported after receiving the COVID-19 vaccine, such as acute encephalopathy. CASE PRESENTATION: In this report, we describe a 32-year-old previously healthy man who developed acute confusion, memory disturbances, and auditory hallucination within 24 hours from getting his first dose of the COVID-19 Moderna vaccine.EEG showed features of encephalopathy, CSF investigations were nonspecific, and MRI head did not depict any abnormality. He received five days of ceftriaxone and acyclovir without any benefit. DISCUSSION: Extensive workup for different causes of acute encephalopathy, including autoimmune encephalitis, was negative. Also, Our patient improved dramatically after receiving methylprednisolone, supporting an immune-mediated mechanism behind his acute presentation. Accordingly, we think the COVID-19 vaccine is the only possible cause of our patient presentation, giving the temporal relationship and the absence of other risk factors for encephalopathy. CONCLUSION: the clinician should be aware of the possible neurological complications of the different COVID-19 vaccines. Further research is needed to clarify the pathophysiology of such complications. |
format | Online Article Text |
id | pubmed-8420261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84202612021-09-07 Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report Al-Mashdali, Abdulrahman F. Ata, Yaser M. Sadik, Nagham Ann Med Surg (Lond) Case Report BACKGROUND: Since introducing the SARS-CoV-2 vaccination, different adverse effects and complications have been linked to the vaccine. Variable neurological complications have been reported after receiving the COVID-19 vaccine, such as acute encephalopathy. CASE PRESENTATION: In this report, we describe a 32-year-old previously healthy man who developed acute confusion, memory disturbances, and auditory hallucination within 24 hours from getting his first dose of the COVID-19 Moderna vaccine.EEG showed features of encephalopathy, CSF investigations were nonspecific, and MRI head did not depict any abnormality. He received five days of ceftriaxone and acyclovir without any benefit. DISCUSSION: Extensive workup for different causes of acute encephalopathy, including autoimmune encephalitis, was negative. Also, Our patient improved dramatically after receiving methylprednisolone, supporting an immune-mediated mechanism behind his acute presentation. Accordingly, we think the COVID-19 vaccine is the only possible cause of our patient presentation, giving the temporal relationship and the absence of other risk factors for encephalopathy. CONCLUSION: the clinician should be aware of the possible neurological complications of the different COVID-19 vaccines. Further research is needed to clarify the pathophysiology of such complications. Elsevier 2021-09-06 /pmc/articles/PMC8420261/ /pubmed/34512961 http://dx.doi.org/10.1016/j.amsu.2021.102803 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Al-Mashdali, Abdulrahman F. Ata, Yaser M. Sadik, Nagham Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title | Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title_full | Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title_fullStr | Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title_full_unstemmed | Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title_short | Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report |
title_sort | post-covid-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420261/ https://www.ncbi.nlm.nih.gov/pubmed/34512961 http://dx.doi.org/10.1016/j.amsu.2021.102803 |
work_keys_str_mv | AT almashdaliabdulrahmanf postcovid19vaccineacutehyperactiveencephalopathywithdramaticresponsetomethylprednisoloneacasereport AT atayaserm postcovid19vaccineacutehyperactiveencephalopathywithdramaticresponsetomethylprednisoloneacasereport AT sadiknagham postcovid19vaccineacutehyperactiveencephalopathywithdramaticresponsetomethylprednisoloneacasereport |